ES2063020T3 - Formulacion medicamentosa de absorcion transdermica. - Google Patents

Formulacion medicamentosa de absorcion transdermica.

Info

Publication number
ES2063020T3
ES2063020T3 ES88120339T ES88120339T ES2063020T3 ES 2063020 T3 ES2063020 T3 ES 2063020T3 ES 88120339 T ES88120339 T ES 88120339T ES 88120339 T ES88120339 T ES 88120339T ES 2063020 T3 ES2063020 T3 ES 2063020T3
Authority
ES
Spain
Prior art keywords
drug formulation
formulation
transdermic
absorption
transdermic absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88120339T
Other languages
English (en)
Inventor
Shinji Kamijo
Jun Imai
Hiromichi Kodaira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2063020T3 publication Critical patent/ES2063020T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE PROPORCIONA UNA FORMULACION DE UNA DROGA ABSORBENTE TRANSDERMAL CONTENIENDO 3-ISOBUTIVIL-2-ISOPROPILPIRAZOLO(1, 5-A)PIRIDINA COMO INGREDIENTE ACTIVO EFECTIVO PARA EL ASMA BRONQUIAL Y PARA EL DESORDEN CEREBROVASCULAR. LA FORMULACION PROPORCIONA UN EXCELENTE ALIVIO SOSTENIDO Y CARACTERISTICAS DE LARGO EFECTO CON EFECTOS SECUNDARIOS SUSTANCIALMENTE REDUCIDOS TAL COMO LA NAUSEA Y EL VOMITO.
ES88120339T 1987-12-10 1988-12-06 Formulacion medicamentosa de absorcion transdermica. Expired - Lifetime ES2063020T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62312593A JPH01153633A (ja) 1987-12-10 1987-12-10 経皮吸収製剤

Publications (1)

Publication Number Publication Date
ES2063020T3 true ES2063020T3 (es) 1995-01-01

Family

ID=18031067

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88120339T Expired - Lifetime ES2063020T3 (es) 1987-12-10 1988-12-06 Formulacion medicamentosa de absorcion transdermica.

Country Status (10)

Country Link
US (1) US5602165A (es)
EP (1) EP0319902B1 (es)
JP (1) JPH01153633A (es)
KR (1) KR950005868B1 (es)
CN (1) CN1033562A (es)
AU (1) AU618976B2 (es)
CA (1) CA1318598C (es)
DE (1) DE3888800T2 (es)
ES (1) ES2063020T3 (es)
HU (1) HU200689B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0225418A (ja) * 1988-07-14 1990-01-26 Kyorin Pharmaceut Co Ltd イブジラスト脂肪乳剤およびその製造方法
JPH08133974A (ja) * 1994-11-04 1996-05-28 Sekisui Chem Co Ltd 経皮吸収貼付剤
GB0524959D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Topical compositions for treatment of respiratory disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5229318B2 (es) * 1972-03-30 1977-08-01
JPS5645507A (en) * 1979-09-21 1981-04-25 Toshiba Electric Equip Lighting device
JPS59167516A (ja) * 1983-03-14 1984-09-21 Kyorin Pharmaceut Co Ltd 抗アレルギ−剤
JPS59167590A (ja) * 1983-03-14 1984-09-21 Kyorin Pharmaceut Co Ltd ピラゾロ〔１，５−ａ〕ピリジン誘導体、その製法及びそれを含有する治療剤
JPH0621066B2 (ja) * 1984-03-14 1994-03-23 杏林製薬株式会社 ３―イソブチリル―２―イソプロピルピラゾロ〔１，５―ａ〕ピリジンの徐放性医薬品組成物
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
JPH01153634A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 吸入剤
DK0431519T3 (da) * 1989-12-04 1994-07-04 Searle & Co System til transdermal indgivelse af albuterol

Also Published As

Publication number Publication date
CA1318598C (en) 1993-06-01
DE3888800T2 (de) 1994-08-11
KR950005868B1 (ko) 1995-06-02
KR890009396A (ko) 1989-08-01
AU618976B2 (en) 1992-01-16
CN1033562A (zh) 1989-07-05
HUT49054A (en) 1989-08-28
HU200689B (en) 1990-08-28
US5602165A (en) 1997-02-11
JPH01153633A (ja) 1989-06-15
EP0319902A2 (en) 1989-06-14
EP0319902A3 (en) 1990-01-31
DE3888800D1 (de) 1994-05-05
AU2649288A (en) 1989-06-15
EP0319902B1 (en) 1994-03-30

Similar Documents

Publication Publication Date Title
ES2186714T3 (es) Uso de sustipo simple alpha 8 en la preparacion de medicamentos para el tratamiento de infecciones virales del higado.
MX9307555A (es) Derivados de paclitaxel y formulaciones farmaceuticas que los contienen.
NO933854L (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
WO1987003480A3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
ES2181682T3 (es) Utilizacion de licopeno para reducir la actividad de las celulas, en particular celulas cancerosas y preparaciones farmaceuticas.
ES2130420T3 (es) Preparado transdermico de sustancia activa.
IT1287114B1 (it) Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
ES2129048T3 (es) Composicion estabilizada de hormona paratiroide.
ES2103952T3 (es) Sistemas terapeuticos transdermicos.
ES2096150T3 (es) Copolimeros vinilicos reticulados, procedimiento para su preparacion, asi como el empleo de estos compuestos.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2034926T1 (es) Composiciones farmaceuticas orales liquidas con actividad anti-inflamatoria.
ES2154021T3 (es) Preparados estimulantes del crecimiento de las uñas.
ES2021167B3 (es) Derivados de pirazol y composiciones insecticidas, miticidas y fungicidas que los contienen, como ingrediente activo
ES2063020T3 (es) Formulacion medicamentosa de absorcion transdermica.
ES2137125B1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
DE3874610D1 (es)
ES2111102T3 (es) Formulaciones cosmeticas y dermatologicas con un contenido activo en acido cis-urocaninico.
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
MX9304456A (es) Composiciones pesticidas estables en almacenamiento que comprenden azadiractina y epoxido.
AU2002328873A1 (en) Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane
ES2026628T3 (es) Un inhalante.
ES2097282T3 (es) Composiciones farmaceuticas para uso como estabilizador de mastocitos.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.
ES2188021T3 (es) Metodo para evitar el uso indebido de un sistema terapeutico percutaneo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 319902

Country of ref document: ES